Moving beyond age-based breast cancer screening towards more personalised approaches to early detection and prevention i...
HighTide Therapeutics, Inc., an innovative biopharmaceutical company specializing in the development of multifunctional,...
Singapore’s biopharmaceutical industry has launched a S$4.8 million study award to strengthen its manufacturing ta...
AI Proteins, Inc., a US-based biotechnology company that utilises computational de novo protein design to create therape...
The global antimicrobial resistance (AMR) research and development community came together in Portugal’s capital, ...
Researchers at the National University of Singapore (NUS) have identified how a stiffer ovarian environment can disrupt ...
Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported...
Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral anti...
The Australian National University (ANU) has been selected as a recipient of the Google.org Impact Challenge: AI for Sci...
Taiwan-based HanchorBio, Inc., a global clinical-stage biotechnology company, and Aston Sci, Inc., a South Korea-based c...
QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an off...
Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximat...
Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...
METiS TechBio, the innovator in AI-powered drug delivery, has announced a strategic collaboration with US-based Eli Lill...
Japan-based TOHO HOLDINGS has invested in AdipoSeeds, Inc., a venture company spun off from Keio University School of Me...
The Coalition for Epidemic Preparedness Innovations (CEPI) and the World Bank Group (WBG), together with Asian Vent...
HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology ...
Cell Therapies Pty Ltd (CTPL) and S2N.Bio have commenced technology transfer of S2N’s cell therapy candidate for A...
Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...
Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facil...
Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...
Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000...
Forty years on, a different question When BioJapan opened its doors for the first time in 1986, Japan's pharmaceutical ...
Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...
